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To the editor: 
Hypothalamic hypocretin neurons are thought to be involved in sleep-wake regulation, energy 
homeostasis, reward networks and motor functions [1] Symptomatic non-narcoleptic 
hypocretin deficient patients may help to understand the functional role of hypocretins in 
humans. We report a case of a 40-year old patient who developed hypersomnia, hyperphagia, 
obesity and apathy as a consequence of bilateral lesions of the posterior hypothalamus and the 
pituitary gland. Fourteen years ago he was diagnosed with pituitary microadenoma and 
panhypopituitarism. Despite stable hormone substitution and antidepressive (escitalopram) 
therapy he recently developed excessive daytime sleepiness (Epworth sleepiness scale 13/24), 
hyperphagia, obesity (BMI 30) and loss of motivation over a six-month period. MRI revealed 
bilateral tumour infiltration in the posterior hypothalamus (details see Fig 1A). The patient did 
not report on cataplexy, sleep paralysis or hallucinations. Hypocretin-1 levels in cerebrospinal 
fluid were decreased (112 pg/ml). 24-hour polysomnography showed a sleep onset REM 
episode and REM sleep (REMS) fragmentation, but normal amount of REMS consistent with 
an enhanced (disinhibited) REMS initiation and a disturbed REMS maintenance (Fig. 1B).  
Similar REMS abnormalities and hypersomnolence have been reported previously in two 
pediatric cases with hypothalamic tumour lesions [2, 3]. In our patient the intake of 
escitalopram may have influenced REMS suppression, but is unlikely to explain the SOREM 
episodes and the loss of REMS cyclicity. A loss of reward seeking behaviour has been 
demonstrated after hypocretin blockade in rats [4] while exploratory behaviour was associated 
with increased firing of the hypocretin neurons [5]. Thus, impaired motivated behaviour due 
to hypocretin cell damage may have contributed to the patient’s apathy and depression. 
Obesity could be explained as a part of the hypothalamic syndrome but also as a result of 
impaired energy homeostasis by hypocretin deficiency.  
We conclude that impaired hypocretin signalling to areas involved in reward regulation may 
result in different combinations of sleep wake disturbances, loss of motivation and emotional 
impairment. Further studies are needed to better understand the interaction between sleep-
wake and reward seeking networks. 
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Fig.1: A - MRI at admission, gadolinium enhanced tumour infiltration in the posterior 
hypothalamus including the mammillary bodies consistent with a Langerhans cell 
histiocytosis; B - Hypnogram over 24 hours. During a 24-hour polysomnography an increase 
of total sleep time (723 minutes), short sleep latency (6.5 minutes) with sleep onset REM 
episode, numerous bouts of REM sleep and high sleep fragmentation were observed. The 
overall amount of REM sleep was not changed. 
 
 
